The forgotten type 2 diabetes mellitus medicine: rosiglitazone
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://link.springer.com/content/pdf/10.1007/s13340-021-00519-0.pdf
Reference130 articles.
1. FDA requires removal of some prescribing and dispensing restrictions for rosiglitazone-containing diabetes medicines. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-requires-removal-some-prescribing-and-dispensing-restrictions. Accessed 22 Mar 2021
2. Yoon KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368(9548):1681–8.
3. Juurlink DN. Rosiglitazone and the case for safety over certainty. JAMA. 2010;304(4):469–71.
4. Durbin RJ. Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance. Diabetes Obes Metab. 2004;6(4):280–5.
5. Rosen CJ. Revisiting the rosiglitazone story–lessons learned. N Engl J Med. 2010;363(9):803–6.
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Are treatment options used for adult-onset type 2 diabetes mellitus (equally) available and effective for children and adolescents?;World Journal of Diabetes;2024-04-15
2. Pioglitazone reverses alcohol‐induced alterations in alveolar macrophage mitochondrial phenotype;Alcohol, Clinical and Experimental Research;2024-03-18
3. Harnessing peroxisome proliferator-activated receptor γ agonists to induce Heme Oxygenase-1: a promising approach for pulmonary inflammatory disorders;Cell Communication and Signaling;2024-02-15
4. Garcinia Biflavonoid 1 from Garcinia kola Ameliorates Glycolipid Metabolism Disorder in Type 2 Diabetic db/db Mice;Natural Product Communications;2024-01
5. Decellularization‐Based Modification Strategy for Bioactive Xenografts Promoting Tendon Repair;Advanced Healthcare Materials;2023-11-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3